US Stock MarketDetailed Quotes
NAVA Nava Health MD
- 6.000
- 0.0000.00%
Close Mar 10 09:30 ET
83.10MMarket Cap-81081P/E (TTM)
0.000High0.000Low0Volume0.000Open6.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)13.85MShares0.00052wk High-28.99P/B16.39MFloat Cap0.00052wk Low--Dividend TTM2.73MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Nava Health MD Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|
| Total revenue | 128.41%3.47M | 37.44%6.66M | 1.78M | 1.52M | 4.84M |
| Operating revenue | 81.24%3.34M | 41.82%6.64M | --1.76M | --1.84M | --4.68M |
| Cost of revenue | 58.00%1.55M | 48.74%3.25M | 771K | 981K | 2.19M |
| Gross profit | 257.28%1.92M | 28.15%3.41M | 1M | 536K | 2.66M |
| Operating expense | 176.12%2.04M | 41.98%4.72M | 2.21M | 737K | 3.32M |
| Selling and administrative expenses | 174.49%2M | 41.50%4.66M | --2.18M | --729K | --3.3M |
| -Selling and marketing expense | 81.87%893K | 22.25%2.19M | --669K | --491K | --1.79M |
| -General and administrative expense | 365.55%1.11M | 64.37%2.48M | --1.51M | --238K | --1.51M |
| Depreciation amortization depletion | 325.00%34K | 104.00%51K | --35K | --8K | --25K |
| -Depreciation and amortization | 325.00%34K | 104.00%51K | --35K | --8K | --25K |
| Operating profit | 40.30%-120K | -97.29%-1.31M | -1.21M | -201K | -664K |
| Net non-operating interest income expense | -2,066.67%-65K | 35.00%-78K | -34K | -3K | -120K |
| Non-operating interest expense | 2,066.67%65K | -35.00%78K | --34K | --3K | --120K |
| Other net income (expense) | 0 | -14.00%1.08M | 579K | 4K | 1.26M |
| Special income (charges) | --0 | 1,646.67%1.05M | --546K | --0 | --60K |
| -Less:Other special charges | ---- | -1,646.67%-1.05M | ---546K | --0 | ---60K |
| Other non- operating income (expenses) | --0 | -97.24%33K | ---- | ---- | --1.2M |
| Income before tax | 7.50%-185K | -164.90%-307K | -664K | -200K | 473K |
| Income tax | |||||
| Net income | 7.50%-185K | -164.90%-307K | -664K | -200K | 473K |
| Net income continuous Operations | 7.50%-185K | -164.90%-307K | ---664K | ---200K | --473K |
| Minority interest income | |||||
| Net income attributable to the parent company | 7.50%-185K | -164.90%-307K | -664K | -200K | 473K |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | 7.50%-185K | -164.90%-307K | -664K | -200K | 473K |
| Basic earnings per share | 7.50%-0.148 | -107.93%-0.03 | -0.3156 | -0.16 | 0.3784 |
| Diluted earnings per share | 7.50%-0.148 | -107.93%-0.03 | -0.3156 | -0.16 | 0.3784 |
| Dividend per share | |||||
| Currency Unit | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg